{"id":"W4308027679","doi":"10.1001/jamaoncol.2022.5357","title":"Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Loxo Oncology; EMD Serono; Genentech; Bausch Health; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; National Institutes of Health; Regeneron Pharmaceuticals; Natera; National Geographic Society; UroGen Pharma; ECOG-ACRIN Cancer Research Group; Seagen; Hope Foundation; Flatiron Health; Vanderbilt University; Advanced Accelerator Applications; National Cancer Institute; Gilead Sciences; Pfizer; Incyte; American Cancer Society; American College of Radiology Imaging Network; Exelixis; Sanofi; American Association for Cancer Research; Amgen; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Interquartile range; Immunosuppression; Cytokine storm; Internal medicine; Cancer; Intensive care unit; Regimen; Retrospective cohort study; Nivolumab; Immunotherapy; Coronavirus disease 2019 (COVID-19)","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004659668,0.0001366836,0.0002866386,0.0004572337,0.0003879988,0.0005490177,0.0001769723,0.0002150726,0.001909611],"category_scores_gemma":[0.002141553,0.00009635199,0.0002857851,0.001091317,0.0002094691,0.0004545069,0.0004266152,0.0004520238,0.0001565433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002320689,"about_ca_system_score_gemma":0.0004708854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001249035,"about_ca_topic_score_gemma":0.002041361,"domain_scores_codex":[0.9994537,0.0001712434,0.00007041375,0.0001054579,0.00008737597,0.0001117921],"domain_scores_gemma":[0.998108,0.0002555385,0.00125562,0.00007291527,0.0001135266,0.0001943054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003576961,0.00001116006,0.9988869,0.000005060077,0.00001478966,0.00003592904,0.00002055975,0.00002125031,0.00007090642,0.00001371333,0.0000592876,0.0008246421],"study_design_scores_gemma":[0.000004425131,0.00008332323,0.9985926,0.00001162459,0.0000200425,0.0004905288,0.000171619,0.0001711515,0.00007043431,0.00004453027,0.0003370568,0.000002689325],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977015,0.0006641488,0.0001424963,0.0001796607,0.00001090726,0.00001128903,0.0005307169,0.000003782178,0.0007555788],"genre_scores_gemma":[0.9992737,0.0001759197,0.00008338087,0.00003820036,0.0000215593,0.000007756324,0.0003309766,0.000001260592,0.00006734015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001909611,"threshold_uncertainty_score":0.006388307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02175855064826714,"score_gpt":0.3903224077173232,"score_spread":0.3685638570690561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}